Indian pharma major Sun Pharma (BSE: 524715) reported positive top-line results from two late-stage studies of its psoriasis ...

The Dutch Ministry of Economic Affairs (EZ) has presented an ambitious action plan to increase public and private investment ...

Pittsburgh, USA-based Viatris, which was formed in 2020 through the merger of Mylan and Pfizer's, saw its shares fall 4.2% to ...

The Psychopharmacologic Drugs Advisory Committee (PDAC) of the US Food and Drug Administration (FDA) met to discuss the supplemental New Drug Application (sNDA) of Rexulti (brexpiprazole) in ...

Research news of note last week included US biotech Crinetics Pharmaceuticals releasing new Phase III data on its acromegaly drug candidate Palsonify (paltusotine). AstraZeneca announced positive ...

As of July 18, 2025, the Food and Drug Administration (FDA) said it has received three reports of fatal acute liver failure ...

US pharma major Bristol Myers Squibb’s shares remained steady, despite the company reporting disappointing results from its ...

The market for selective estrogen receptor modulators, or SERMs, is poised for considerable growth over the next decade, ...

Scottish biotech Trogenix has announced two senior appointments as the company advances its pipeline towards the clinic.

US biotech TRIO Pharmaceuticals has announced the appointment of Patrick Doyle as chief executive (CEO effective immediately.

US healthcare giant Johnson & Johnson announced that the prestigious medical journal The Lancet has published positive ...

In what is not exactly a win-win situation for the Indian generic firms, a recent federal court ruling in Delaware, USA, has ...